Showing results (51-60 of 160) with videos related to
Sort By:
Pageof 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2016
Quantitative Accuracy and Lesion Detectability of Low-Dose 18F-FDG PET for Lung Cancer ScreeningJoshua D Schaefferkoetter, Jianhua Yan, Therese Sjöholm, et al.The Lancet. Oncology|November 3, 2009
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009Ross A Soo, Benjamin O Anderson, Byoung Chul Cho, et al.Expert Review of Anticancer Therapy|August 8, 2023
Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung CancerJerold Loh, Jia Li Low, Manavi Sachdeva, et al.Future Oncology (London, England)|April 21, 2012
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapyRoss A Soo, Tomoya Kawaguchi, Marie Loh, et al.BMC Cancer|October 11, 2011
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerYi-Long Wu, Keunchil Park, Ross A Soo, et al.Cancer Chemotherapy and Pharmacology|February 29, 2008
Does saturable formation of gemcitabine triphosphate occur in patients?Lai-San Tham, Ling-Zhi Wang, Ross A Soo, et al.Therapeutic Advances in Medical Oncology|September 19, 2022
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE studyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trialsRoss A Soo, Marie Loh, Tony S Mok, et al.Lung Cancer (Amsterdam, Netherlands)|October 9, 2023
Management of HER2 alterations in non-small cell lung cancer - The past, present, and futureJorn Nützinger, Jii Bum Lee, Jia Li Low, et al.Clinical Pharmacology in Drug Development|January 16, 2025
A Drug-Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non-Small Cell Lung CancerMichael J Hanley, Steven Zhang, Nick Pavlakis, et al.Pageof 16